Journal Technologies of Living Systems №3 for 2024 year
Immune checkpoints and their soluble forms in bone tumors

N.E. Kushlinskii1, A.A. Alferov2, Yu.B. Kuzmin3, P.L. Prishchep4, I.S. Chernomaz5, N.Yu. Sokolov6, I.N. Kuznetsov7, I.S. Stilidi8

1,2,4-6,8 N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia (Moscow, Russia)

3,7 Russian University of Medicine of the Ministry of Health of Russia (Moscow, Russia)

1 kne3108@gmail.com, 2 aleksandr.alferov@yahoo.com, 3 yriikuzmin@yandex.com, 4 Paulig92@mail.ru, 5 marvel2602@mail.ru, 6 strivp@mail.ru, 7 npkredo@yandex.ru, 8 ronc@list.ru

7-36
Method for detecting perineural and intraneural invasion in breast cancer as a prognostic factor of tumor progression

M.V. Mnikhovich1, L.M. Erofeeva2, T.V. Bezuglova3, I.A. Shiripenko4, M.V. Lozina5, B.V. Malygin6, N.E. Kushlinskii7

1–5 Avtsyn Research Institute of Human Morphology of FSBSI «Petrovsky National Research Centre of Surgery» (Moscow, Russia)

4–6 Pirogov Russian National Research Medical University (Moscow, Russia)

7 N.N. Blokhin National Medical Research Center of Oncology
of the Ministry of Healthcare of the Russian Federation (Moscow, Russia)

1 mnichmaxim@yandex.ru, 7 biochimia@yandex.ru

37-44
Possibilities of using parnaparin sodium in oncology

O.V. Somonova1, A.L. Elizarova2, A.V. Sytov3, M.I. Timoshkov4, I.V. Babkina5, M.A. Kononov6

1–3,5,6 N.N. Blokhin National Medical Research Center of Oncology
of the Ministry of Health of the Russian Federation (Moscow, Russia)

4 G.B. Mirzoev Russian University of Advocacy and Notariate (Moscow, Russia)

1 somonova@mail.ru, 2 anna_el@rambler.ru, 3 drsytov@rambler.ru, 5 docbabkina@rambler.ru

45-52
Tumor-specific and tumor-associated antigens as targets for immunotherapy

P.A. Podlesnaya1, O.V. Kovaleva2, O.S. Malashenko3, A.N. Gratchev4, I.S. Chernomaz5, P.L. Prishchep6, M.L. Filipenko7, N.E. Kushlinskii8

1–6,8 Federal State Budgetary Institution «N.N. Blokhin National Medical Research Center of Oncology»
of the Ministry of Health of Russia (Moscow, Russia)

7 Federal State Budgetary Institution of Science Institute of Chemical Biology and Fundamental Medicine
of the Siberian Branch of the Russian Academy of Sciences (Novosibirsk, Russia)

1 polina.pod@yandex.ru, 2 ovkovaleva@gmail.com, 3 o.malashenko@ronc.ru, 4 alexei.gratchev@gmail.com, 5 Paulig92@mail.ru, 6 marvel2602@mail.ru, 7 mlfilipenko@gmail.com, 8 kne3108@gmail.com

53-66
The first experience of using autohemotherapy technology for degenerative changes in the macula

F.V. Donenko1, Yu.S. Lebedin2

1 N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation (Moscow, Russia)

2 HEMA LLC (Moscow, Russia)

1 donenko.f20010@yandex.ru

67-73
Clinical significance of methylation of lncRNA genes MEG3, SEMA3B-AS1 in tumors of patients with luminal breast cancer

A.A. Osipova1, D.A. Ryabchikov2, S.V. Chulkova3, A.M. Burdennyy4, V.I. Loginov5, N.E. Kushlinskii6

1,6 Russian University of Medicine (Moscow, Russia)

2,3,6 N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia (Moscow, Russia)

3 I.I. Pirogov Russian National Research Medical University of the Russian Ministry of Health (Moscow, Russia)

4,5 Research Institute of General Pathology and Pathophysiology (Moscow, Russia)

5 Research Centre for Medical Genetics, (Moscow, Russia)

1 osipova_ronc@mail.ru

74-83
The relationship between galectins 1, 3 and growth factors and the expression of growth factors and their receptors in colorectal cancer

A.V. Kurnosenko1, G.V. Reinhardt2, V.S. Poletika3, Yu.V. Kolobovnikova4, A.I. Dmitrieva5, M.Yu. Grishchenko6, V.K. Abramov7, O.I. Urazova8

1–4, 6–8 Federal State Budgetary Educational Institution of Higher Education «Siberian State Medical University» of the Ministry of Health of Russia (Tomsk, Russia)

1,5 Regional State Autonomous Healthcare Institution «Tomsk Regional Oncology Center» (Tomsk, Russia)

8 urazova72@yandex.ru

84-91